Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
NAORIS (NaorisProtocol) 24-hour volatility reaches 40.8%: trading volume surges over 270% driving rebound

NAORIS (NaorisProtocol) 24-hour volatility reaches 40.8%: trading volume surges over 270% driving rebound

Bitget PulseBitget Pulse2026/04/27 05:55
Show original
By:Bitget Pulse

Volatility Overview

In the past 24 hours, NAORIS price rebounded from a low of $0.06747 to a high of $0.095, currently quoted at $0.09362, with a volatility amplitude of 40.8%. The 24-hour trading volume is approximately $5.5–6.2 million, a sharp increase of 274%-280% compared to the previous day, with futures trading volume at nearly $5 million far surpassing spot at $335,000.

Brief Analysis of the Cause of the Price Movement

- Trading volume significantly enlarged, especially Binance futures with $2.27 million traded in 24 hours and an open interest of $13.66 million, driving the price to rebound from the lows.

- Price broke through the long-term horizontal accumulation range, forming a strong impulsive candlestick with increased trading volume. There was no clear external announcement, but technical patterns attracted capital rotation.

- Low spot liquidity (extremely low trading volume last week) amplified volatility, and the push-up in spot trading is suspected to have cleaned out inactive traders.

Market Views and Outlook

Market sentiment is 85% bullish. Most traders are signaling long positions expecting continued breakout (entry at $0.078–0.084, targeting $0.09–0.13), but warning that low liquidity could lead to pump-and-dump risks. Attention should be paid to the $0.067–0.070 support levels.

Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational purposes only.
1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs Upgrades CoreWeave to "Buy": Market Overestimates Financing Costs and Underestimates Computing Fee Capabilities

Goldman Sachs has upgraded CoreWeave’s rating from “Neutral” to “Buy,” with a target price of $106, offering approximately 73% upside from the latest closing price of $61.39. Goldman Sachs believes the market is overly concerned about CoreWeave’s financing costs but underestimates its charging potential for computing power: asset-backed financing supported by GPU and customer contracts is not entirely tied to corporate bond yields. Additionally, annual revenue per megawatt is expected to rise from the current $10 million to $13 million, improving investment returns.

华尔街见闻•2026/10/19 13:01
Goldman Sachs Upgrades CoreWeave to "Buy": Market Overestimates Financing Costs and Underestimates Computing Fee Capabilities

AI Credit Pressure Surfaces: CoreWeave Bonds Become the New Barometer for the US Stock Market

CoreWeave's unsecured bonds have replaced Nvidia as the market's "beta barometer" for measuring AI trades. The bonds’ yields have surged past 16% and CDS spreads have soared, highlighting the high dependence of emerging cloud computing companies on debt financing and their funding gap risks. Credit pressures are spreading from infrastructure to equity markets, and the main focus of AI trading has shifted from computing power demand to financing costs and sustainability.

华尔街见闻•2026/10/19 12:46
AI Credit Pressure Surfaces: CoreWeave Bonds Become the New Barometer for the US Stock Market

GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window

The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.

智通财经•2026/10/19 11:37
GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window

After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"

Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.

智通财经•2026/10/19 11:18